N/A
Completed N=50
A New Glucose Meter With Alternative Site Testing
Source: ClinicalTrials.gov NCT00797212 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Dec 2009
Primary outcomePrimary: Number of AST Results Within +/- 15mg/dL or +/- 20% of Fingerstick (FS)Blood Glucose Results — 96; 93 number of AST Blood Glucose Results
Summary
The purpose of the study was to evaluate the performance of the blood glucose monitoring system when used with samples taken from the palm and forearm for alternative site testing (AST).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of AST Results Within +/- 15mg/dL or +/- 20% of Fingerstick (FS)Blood Glucose Results |
96; 93 | — |
| SECONDARY Percentage of Participants Rated as <=3 (Labeling Comprehension) |
100; 100 | — |
| SECONDARY Percentage of Participant Ratings for Overall Testing Experience With This Meter |
68; 26; 6; 0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Have type 1 or type 2 diabetes
- Be >18 75 years of age
- Pregnancy
- Physical (dexterity), visual, or neurological impairments that would make the person unable to perform testing with the BGMS
- Disorders in the fingertip lancing areas
- Acute or chronic infections, particularly skin infections
- Infection with a blood borne pathogen
- Taking prescription anti-coagulants or having clotting problems that may prolong bleeding. Taking aspirin daily (81mg or 325 mg) is not reason for exclusion.
- Hemophilia or any other bleeding disorder
- Having a condition which, in the opinion of the Principal Investigator or designee, would put the person at risk or seriously compromise the integrity of the study
- Working for a competitive medical device company
Data sourced from ClinicalTrials.gov (NCT00797212). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.